Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$75,000.00
Mar 16, 2026
For-profit organization
Market Study for the Development of a Wound-Healing Product
1040122
The project involves studying the European defence market for a wound-healing product
$75,000.00
Dec 8, 2025
For-profit organization
Development of a Chitosan–Silver Nanoparticles-Based Topical Ointment Formulation Effective Against Antibiotic-Resistant Wound Pathogens.
1038016
The project aims to develop advanced chitosan–silver nanoparticles wound dressings with enhanced antimicrobial performance. The project will investigate synergistic combinations of chitosan- and silver nanoparticles to intensify antimicrobial action against antibiotic-resistant bacteria, while limiting silver concentration.
$75,000.00
Jun 16, 2025
For-profit organization
Development of a prototype formulation efficient against ophthalmologic infections
1029471
The aim of the project is to develop formulation and to test their efficiency against N. gonorrhoeae.
$75,000.00
Sep 9, 2024
For-profit organization
PRA - High anti biofilm formulation
1022441
Development of next generation of dental unit waterline disinfectants
$25,380.00
Dec 1, 2023
For-profit organization
IP Assist L3: Intellectual Property Strategy Engagement
1013374
The project will support development of intellectual property capacity within the firm.
$66,560.00
Aug 1, 2022
For-profit organization
Development of the biopolymers with the incorporated silver nanoparticles, to be used as absorbent pads in food packages, for the prolongating the storage of fresh fruits and vegetables.
991594
The aim of the project is the development of an antimicrobial absorbent pad with silver nanoparticles for food packaging containers.
$10,000.00
Jul 1, 2022
For-profit organization
IP-Assist L2
991742
The project will fund the development of the firm's intellectual property capacity
$327,130.00
Feb 21, 2022
For-profit organization
Development of commercial health applications based on gold and silver nanoparticles
986664
The objective of the project is to develop novel antibacterial products by combining silver nanoparticles with plant extracts known for their antibacterial effects, as well as a rapid, precise detection kit for detecting low concentrations of Pb in drinking water.
$248,654.00
Nov 16, 2020
For-profit organization
400058764
400058764
Working Capital: In the context of the crisis caused by the COVID-19 pandemic, the project aims to ensure the continuity of operations of a company that specializes in the manufacture of basic ingredients for the pharmaceutical industry.
$54,061.00
Nov 16, 2020
For-profit organization
400058764
400058764
Working capital : In the context of the crisis caused by the pandemic at COVID-19, the project aims to ensure the continuity of operations of a company specializing in the manufacture of basic ingredients for the pharmaceutical industry.